Seeking Alpha

CLTX
  Celsus Therapeutics - NASDAQ

11/28/2014, 8:33 PM ET
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
CLTX vs. ETF Alternatives
Company Description
Celsus Therapeutics PLC is a development stage company. The Company is engaged in the development of ethical synthetic drugs for the treatment of severe chronic inflammatory conditions such as contact dermatitis, etc.
Sector: Healthcare
Industry: Biotechnology
Country: United States